The antidepressant medicine sales in Germany stood at 1.00 billion USD PPP in 2023. Based on the provided forecast, sales are expected to rise from 1.01 billion USD PPP in 2024 to 1.07 billion USD PPP by 2028. This indicates a steady year-on-year growth, with variations between 1.01% and 1.94% annually. The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is approximately 1.38%.
Future trends to watch for include innovations in antidepressant treatments, increasing awareness and diagnosis of mental health issues, potential economical fluctuations affecting healthcare spending, and the impact of regulatory changes in the pharmaceutical sector.
